{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T18:28:05Z","timestamp":1791224885473,"version":"4.1.0"},"reference-count":36,"publisher":"Wiley","issue":"1","license":[{"start":{"date-parts":[[2004,12,9]],"date-time":"2004-12-09T00:00:00Z","timestamp":1102550400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Eur J of Neuroscience"],"published-print":{"date-parts":[[2005,1]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Repeated exposure to amphetamine (AMPH) leads to the development of behavioural sensitization that can be demonstrated in rats as enhanced locomotor responding to and self\u2010administration of the drug. Glutamate systems are known to participate in the induction and expression of sensitization by psychostimulants. Group\u2003II metabotropic glutamate receptors (mGluRs), because they negatively regulate both vesicular and nonvesicular glutamate release, are thus well positioned to gate its expression. Here we report that the expression of locomotor sensitization by AMPH is completely prevented by a systemic injection of the selective group\u2003II mGluR agonist LY379268 at a dose that produced no effects when administered alone. The activation of group\u2003II mGluRs in AMPH\u2010sensitized rats also reduced the enhanced overflow of both dopamine and glutamate normally observed in the nucleus accumbens, a brain region critical for the generation of locomotor and drug self\u2010administration behaviours. To directly determine the effect of group\u2003II mGluR activation on enhanced drug self\u2010administration, AMPH\u2010sensitized rats were allowed to self\u2010administer a mixture of LY379268 and AMPH. These rats continued to self\u2010administer but did not exhibit the enhanced work output and drug intake observed in AMPH\u2010sensitized rats self\u2010administering AMPH alone. Thus, activating group\u2003II mGluRs prevents the expression of different manifestations of AMPH sensitization including enhanced self\u2010administration of the drug. These receptors may represent a potentially important target for therapeutic intervention directed at drugs of abuse.<\/jats:p>","DOI":"10.1111\/j.1460-9568.2004.03822.x","type":"journal-article","created":{"date-parts":[[2005,1,12]],"date-time":"2005-01-12T14:58:38Z","timestamp":1105541918000},"page":"295-300","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":70,"title":["Activation of group\u2003II mGlu receptors blocks the enhanced drug taking induced by previous exposure to amphetamine"],"prefix":"10.1111","volume":"21","author":[{"given":"Jeong\u2010Hoon","family":"Kim","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer D.","family":"Austin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lauren","family":"Tanabe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth","family":"Creekmore","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"Vezina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2005,1,10]]},"reference":[{"key":"e_1_2_11_2_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1460-9568.1997.tb01430.x"},{"key":"e_1_2_11_3_1","doi-asserted-by":"publisher","DOI":"10.1523\/JNEUROSCI.22-20-09134.2002"},{"key":"e_1_2_11_4_1","doi-asserted-by":"publisher","DOI":"10.1523\/JNEUROSCI.0176-04.2004"},{"key":"e_1_2_11_5_1","first-page":"161","article-title":"The metabotropic glutamate 2\/3 receptor agonists LY354740 and LY379268 selectively attenuate phencyclidine versus d\u2010amphetamine motor behaviors in rats","volume":"291","author":"Cartmell J.","year":"1999","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"e_1_2_11_6_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0014-2999(00)00423-4"},{"key":"e_1_2_11_7_1","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1007\/s002130050072","article-title":"Attenuation of specific PCP\u2010evoked behaviors by the potent mGlu2\/3 receptor agonist, LY379268 and comparison with the atypical antipsychotic, clozapine","volume":"148","author":"Cartmell J.","year":"2000","journal-title":"Psychopharmacology"},{"key":"e_1_2_11_8_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0028-3908(01)00034-X"},{"key":"e_1_2_11_9_1","first-page":"412","article-title":"The regulation of dopamine transmission by metabotropic glutamate receptors","volume":"289","author":"Hu G.","year":"1999","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"e_1_2_11_10_1","first-page":"478","article-title":"Interactions between excitatory amino acids and dopamine systems in the forebrain: Implications for schizophrenia and Parkinson's disease","volume":"6","author":"Iversen S.D.","year":"1995","journal-title":"Behav. Pharmacol."},{"key":"e_1_2_11_11_1","doi-asserted-by":"publisher","DOI":"10.1016\/0306-4522(93)90048-K"},{"key":"e_1_2_11_12_1","first-page":"962","article-title":"Activation of metabotropic glutamate receptors in the rat nucleus accumbens increases locomotor activity in a dopamine\u2010dependent manner","volume":"283","author":"Kim J.\u2010H.","year":"1997","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"e_1_2_11_13_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0028-3908(98)00015-X"},{"key":"e_1_2_11_14_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0091-3057(02)00827-4"},{"key":"e_1_2_11_15_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0306-4522(02)00652-8"},{"key":"e_1_2_11_16_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1460-9568.1997.tb01506.x"},{"key":"e_1_2_11_17_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0006-8993(98)00941-X"},{"key":"e_1_2_11_18_1","doi-asserted-by":"publisher","DOI":"10.1126\/science.281.5381.1349"},{"key":"e_1_2_11_19_1","doi-asserted-by":"publisher","DOI":"10.1016\/0306-4522(93)90485-X"},{"key":"e_1_2_11_20_1","doi-asserted-by":"publisher","DOI":"10.1002\/cne.903350209"},{"key":"e_1_2_11_21_1","doi-asserted-by":"publisher","DOI":"10.1126\/science.2781295"},{"key":"e_1_2_11_22_1","doi-asserted-by":"publisher","DOI":"10.1523\/JNEUROSCI.16-04-01550.1996"},{"key":"e_1_2_11_23_1","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1098-2396(199710)27:2<95::AID-SYN1>3.3.CO;2-L"},{"key":"e_1_2_11_24_1","doi-asserted-by":"publisher","DOI":"10.1016\/0165-0270(95)00153-0"},{"key":"e_1_2_11_25_1","doi-asserted-by":"publisher","DOI":"10.1016\/0165-0173(93)90013-P"},{"key":"e_1_2_11_26_1","first-page":"12","article-title":"Unveiling the functions of presynaptic metabotropic glutamate receptors in the central nervous system","volume":"299","author":"Schoepp D.D.","year":"2001","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"e_1_2_11_27_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0028-3908(99)00092-1"},{"key":"e_1_2_11_28_1","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1096-9861(19980105)390:1<5::AID-CNE2>3.3.CO;2-C"},{"key":"e_1_2_11_29_1","doi-asserted-by":"publisher","DOI":"10.1007\/s002130000493"},{"key":"e_1_2_11_30_1","doi-asserted-by":"crossref","first-page":"2411","DOI":"10.1523\/JNEUROSCI.16-07-02411.1996","article-title":"D1 dopamine receptor activation is necessary for the induction of sensitization by amphetamine in the ventral tegmental area","volume":"16","author":"Vezina P.","year":"1996","journal-title":"J. Neurosci."},{"key":"e_1_2_11_31_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.neubiorev.2003.11.001"},{"key":"e_1_2_11_32_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0149-7634(98)00055-4"},{"key":"e_1_2_11_33_1","doi-asserted-by":"publisher","DOI":"10.1523\/JNEUROSCI.22-11-04654.2002"},{"key":"e_1_2_11_34_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0301-0082(97)00090-7"},{"key":"e_1_2_11_35_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1471-4159.2000.0751634.x"},{"key":"e_1_2_11_36_1","doi-asserted-by":"publisher","DOI":"10.1124\/jpet.102.039735"},{"key":"e_1_2_11_37_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1471-4159.1996.67010352.x"}],"updated-by":[{"DOI":"10.1111\/j.1460-9568.2007.05464.x","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2007,2,16]],"date-time":"2007-02-16T00:00:00Z","timestamp":1171584000000}}],"container-title":["European Journal of Neuroscience"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1460-9568.2004.03822.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1460-9568.2004.03822.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,10]],"date-time":"2023-10-10T06:04:30Z","timestamp":1696917870000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1460-9568.2004.03822.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,1]]},"references-count":36,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2005,1]]}},"alternative-id":["10.1111\/j.1460-9568.2004.03822.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1460-9568.2004.03822.x","archive":["Portico"],"relation":{},"ISSN":["0953-816X","1460-9568"],"issn-type":[{"value":"0953-816X","type":"print"},{"value":"1460-9568","type":"electronic"}],"subject":[],"published":{"date-parts":[[2005,1]]},"assertion":[{"value":"2005-01-10","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}